Status:
UNKNOWN
Multidisciplinary Treatment of Obesity Prior to in Vitro Fertilization: Impact on Global Reproductive Outcomes (PRO-FIV Study)
Lead Sponsor:
Hospital Clinic of Barcelona
Conditions:
Obesity
Infertility
Eligibility:
FEMALE
18-40 years
Phase:
NA
Brief Summary
The aim of the present study is to evaluate the impact of a multidisciplinary treatment of obesity prior to IVF on global reproductive outcomes and maternofetal metabolic and cardiovascular risk facto...
Detailed Description
The aim of the present study is to evaluate the impact of a multidisciplinary treatment of obesity prior to IVF on global reproductive outcomes and maternofetal metabolic and cardiovascular risk facto...
Eligibility Criteria
Inclusion
- Obese infertile patients (body mass index ≥ 30 Kg/m2) prior to an in vitro fertilization cycle
Exclusion
- Pathological conditions: diabetes type I, Cushing syndrome, premature ovarian failure, uncontrolled thyroidal dysfunction, hepatic and/or renal dysfunction, antiphospholipid syndrome, medical condition that contraindicate ovarian stimulation and/or pregnancy
- Simultaneous practice of another strategy to lose weight
- Physical conditions limiting exercise training
- Patients unable to understand spanish language or to give informed consent
Key Trial Info
Start Date :
January 28 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2020
Estimated Enrollment :
104 Patients enrolled
Trial Details
Trial ID
NCT03395067
Start Date
January 28 2018
End Date
December 1 2020
Last Update
January 30 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Clínic de Barcelona
Barcelona, Spain, 08036